Effective assay technologies fit for large-scale population screening of type 1 diabetes

Effective assay technologies fit for large-scale population screening of type 1 diabetes

While worldwide prevention efforts for type 1 diabetes (T1D) are underway to abrogate or slow progression to diabetes, mass screening of islet autoantibodies (IAbs) in the general population is urgently needed. IAbs, the most reliable biomarkers, play an essential role in prediction and clinical dia...

Full description

Bibliographic Details
Main Authors:	Xiaofan Jia, Liping Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Clinical Diabetes and Healthcare
Subjects:	type 1 diabetes autoantibodies screening prediction biomarkers
Online Access:	https://www.frontiersin.org/articles/10.3389/fcdhc.2022.1034698/full

Similar Items

Early autoantibody screening for type 1 diabetes: a Kuwaiti perspective on the advantages of multiplexing chemiluminescent assays
by: Fahd Al-Mulla, et al.
Published: (2023-11-01)

Autoantibody test for type 1 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP)
by: Valentino Cherubini, et al.
Published: (2023-07-01)

An online diabetic retinopathy screening tool for patients with type 2 diabetes
by: Wan-Yue Li, et al.
Published: (2021-11-01)

Profile of auto-antibodies (Disease related and other) in children with type 1 diabetes
by: Madhurima Basu, et al.
Published: (2020-01-01)

Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes
by: Seung Ho Lee, et al.
Published: (2016-12-01)

The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
by: Navoda Atapattu, et al.
Published: (2023-02-01)

Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma‐associated antigen‐2 and zinc transporter 8
by: Eiji Kawasaki, et al.
Published: (2021-04-01)

Diagnostic value of combined islet antigen‐reactive T cells and autoantibodies assays for type 1 diabetes mellitus
by: Wei Tang, et al.
Published: (2021-06-01)

Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
by: Eiji Kawasaki, et al.
Published: (2020-11-01)

Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes
by: Janet M. Wenzlau, et al.
Published: (2023-09-01)

Making type and screen policy an essential component of pretransfusion testing: Need of the hour in India
by: Rasika Setia, et al.
Published: (2017-01-01)

RELATION OF ISLET CELLS ANTIBODIES AND RESIDUAL FUNCTION OF PANCREAS IN PATIENTS WITH DIABETES TYPE I
by: T. A. Tihomirova, et al.
Published: (2014-07-01)

Serum autoantibody profiling of oral squamous cell carcinoma patients reveals NUBP2 as a potential diagnostic marker
by: Riaz Abdulla, et al.
Published: (2023-09-01)

Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital
by: Rumei Li, et al.
Published: (2018-05-01)

The Multifactorial Progression from the Islet Autoimmunity to Type 1 Diabetes in Children
by: Witold Bauer, et al.
Published: (2021-07-01)

Performance of Stepwise Screening Methods in Identifying Individuals at High Risk of Type 2 Diabetes in an Iranian Population
by: Mojtaba Lotfaliany, et al.
Published: (2022-08-01)

C-peptide levels and the prevalence of islets autoantibodies in children with type 1 diabetes mellitus with different duration of the disease
by: E. M. Romanenkova, et al.
Published: (2022-05-01)

Evaluation for type 1 diabetes associated autoantibodies in diabetic and non-diabetic Australian terriers and Samoyeds
by: Allison L. O’Kell, et al.
Published: (2020-08-01)

The role of specific pancreatic antibodies in the differential diagnosis of complete clinical and laboratory remission of type 1 diabetes mellitus and MODY in children
by: E. A. Sechko, et al.
Published: (2022-12-01)

Gene expression signature predicts rate of type 1 diabetes progressionResearch in context
by: Tomi Suomi, et al.
Published: (2023-06-01)

Leukocyte Composition and Immunophenotype of Peripheral Blood Lymphocytes in Children and Adolescents, Who are DAAb-Positive and DAAb-Negative in Terms of Diabetes-Associated Autoantibodies, on the Preclinical and Early Clinical Stages of Type 1 Diabet
by: V.V. Popova
Published: (2015-03-01)

Comparing the clinical significance and antigen specificity of insulinoma‐associated antigen‐2 autoantibodies between radioimmunoassay and enzyme‐linked immunosorbent assay in Japanese patients with type 1 diabetes
by: Eiji Kawasaki, et al.
Published: (2023-01-01)

Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay
by: Devangkumar Tandel, et al.
Published: (2024-02-01)

Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
by: Young Hwa Kong, et al.
Published: (2013-06-01)

Development of a Novel Circulating Autoantibody Biomarker Panel for the Identification of Patients with ‘Actionable’ Pulmonary Nodules
by: Claire Auger, et al.
Published: (2023-04-01)

Development of a salivary autoantibody biomarker panel for diagnosis of oral cavity squamous cell carcinoma
by: Pei-Chun Hsueh, et al.
Published: (2022-10-01)

Immunological predictors of type 1 diabetes mellitus (literature review)
by: K. G. Korneva, et al.
Published: (2021-07-01)

Markers for hepatic autoimmune disorders in patients with type 1 diabetes mellitus
by: Olga Sergeevna Derevyanko, et al.
Published: (2014-03-01)

False negatives of screening in large-scale population
by: XU Ning, et al.
Published: (2022-05-01)

Rheumatoid Factor: A Novel Determiner in Cancer History
by: Alessio Ugolini, et al.
Published: (2021-02-01)

Association between enterovirus infection and type 1 diabetes: new findings from Cuban studies
by: Luis Sarmiento, et al.

Autoantibodies in Type 1 Diabetes: A Retrospective Study of Children Diagnosed Under Ten Years of Age
by: Cristiana Maximiano, et al.
Published: (2023-09-01)

Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study
by: Gum Bit Hwang, et al.
Published: (2018-03-01)

Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma‐associated antigen‐2 autoantibodies in the identification and characterization of Japanese type 1 diabetes
by: Eiji Kawasaki, et al.
Published: (2020-09-01)

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1
by: Shenghua Zong, et al.
Published: (2023-05-01)

Glutamic Acid Decarboxylase and Tyrosine Phosphatase-Related Islet Antigen-2 Positivity among Children and Adolescents with Diabetes in Korea
by: Ka Young Kim, et al.
Published: (2022-11-01)

Development and Validation of a Deep Learning Based Diabetes Prediction System Using a Nationwide Population-Based Cohort
by: Sang Youl Rhee, et al.
Published: (2021-07-01)

Use of the FINDRISC Questionnaire in the Uzbek Population as a First Stage of Screening for Type 2 Diabetes Mellitus
by: Anna V. Alieva, et al.
Published: (2020-03-01)

Zinc transporter 8 autoantibody in the diagnosis of type 1 diabetes in children
by: Nur Rochmah, et al.
Published: (2020-10-01)

Prevalence of Autoantibodies Against Pancreatic Beta Cells in Children with Type 1 Diabetes Mellitus
by: Zahra Panahivand, et al.
Published: (2023-12-01)